Stada appoints Goldschmidt as permanent CEO

1 February 2018 - Deborah Wilkes

Stada Arzneimittel has appointed Peter Goldschmidt – a senior executive at Novartis' Sandoz division – as its new permanent chief executive officer. He will be the German generics and OTC company's fifth chief executive officer in around two years.